- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03206515
The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones
June 29, 2017 updated by: Guohua Zeng, The First Affiliated Hospital of Guangzhou Medical University
The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones: A Randomized Controlled Trial
Percutaneous nephrolithotomy (PNL) has been considered as the first-line choice for the management of >20mm kidney stones.
Microchannel percutaneous nephrolithotomy (Mini PCNL) which takes nephrolithotomy channel size less than or equal to 18, was first used in the treatment of children with kidney stones in 1997, then gradually applied to adult, aims to achieve the similar stone clearance rate as the standard channels, at the same time, reduce the complications.
At present, the use of percutaneous renal surgery in our country is more than 18F plastic peel-away sheath, with the access sheath with a suction-evacuation function was first used by Guohua Zeng and so on.
But there is still a lack of high quality evidence of Evidence-based medical evidence to compare the two kinds of sheath for the safety and effectiveness.
Therefore, this study provides a reliable theoretical basis for the choice of the sheath for the treatment of 2-5cm size Kidney, and ultimately benefit patients with 20mm.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Percutaneous nephrolithotomy (PNL) has been considered as the first-line choice for the management of >20mm kidney stones.
Microchannel percutaneous nephrolithotomy (Mini PCNL) which takes nephrolithotomy channel size less than or equal to 18, was first used in the treatment of children with kidney stones in 1997, then gradually applied to adult, aims to achieve the similar stone clearance rate as the standard channels, at the same time, reduce the complications.
At present, the use of percutaneous renal surgery in our country is more than 18F plastic peel-away sheath, with the access sheath with a suction-evacuation function was first used by Guohua Zeng and so on.
But there is still a lack of high quality evidence of Evidence-based medical evidence to compare the two kinds of sheath for the safety and effectiveness.
Therefore, this study provides a reliable theoretical basis for the choice of the sheath for the treatment of 2-5cm size Kidney, and ultimately benefit patients with 20mm.
Study Type
Interventional
Enrollment (Anticipated)
86
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510230
- Recruiting
- epartment of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients consent for percutaneous renal stone removal
- Age 18 to 70 years
- Normal renal function
- ASA score Ⅰ and Ⅱ
- Renal stones 20-50mm
Exclusion Criteria:
- Patients with solitary kidney
- Uncorrected coagulopathy and active urinary tract infection (UTI)
- Morbid obese patients
- Patients who underwent transplant or urinary diversion
- Congenital abnormalities
- Patients will be excluded from the study if the undergoing standard PNL/mini-perc have purulent fluid in the initial puncture
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Group 1
Patients in Group 1 undergo Mini Percutaneous Nephrolithotomy with The 18F peel-way sheath group
|
Patients undergoing Mini Percutaneous Nephrolithotomy with The 18F peel-way sheath
|
|
Other: Group 2
Patients in Group 2 undergo Mini Percutaneous Nephrolithotomy with The 18F access sheath with a suction-evacuation function group
|
Patients undergoing Mini Percutaneous Nephrolithotomy with The 18F access sheath with a suction-evacuation function
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The renal pelvic pressure
Time Frame: During the procedure
|
To measure the renal pelvic pressure during mini-PCNL procedure
|
During the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perioperative complications
Time Frame: Intraoperatively or ≤ 1 month postoperatively
|
Invaluate perioperative complications by modified Clavien system
|
Intraoperatively or ≤ 1 month postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Anticipated)
December 1, 2017
Study Completion (Anticipated)
December 1, 2017
Study Registration Dates
First Submitted
October 27, 2016
First Submitted That Met QC Criteria
June 29, 2017
First Posted (Actual)
July 2, 2017
Study Record Updates
Last Update Posted (Actual)
July 2, 2017
Last Update Submitted That Met QC Criteria
June 29, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MRER(17)2016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Calculi
-
Amai Charitable TrustUnknown
-
Changhai HospitalThe First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaboratorsUnknown
-
Institute for the Study of Urological Diseases,...CompletedRenal Insufficiency | Renal CalculiGreece
-
Hadassah Medical OrganizationGrumentalCompletedRenal CalculusIsrael
-
Kırıkkale UniversityCompletedKidney Calculi Nephrolithiasis Urolithiasis Renal Stone
-
Al-Azhar UniversityRecruiting
-
Ain Shams UniversityCompleted
-
Mansoura UniversityCompleted
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterCompleted
-
Seoul National University HospitalSK Telecom ConsortiumCompleted
Clinical Trials on 18F Peel-Way Sheath
-
Thomas HopeRecruiting
-
Radboud University Medical CenterTerminatedLiver Neoplasms | Colorectal NeoplasmsNetherlands
-
Stephen HarbarthEuropean CommissionUnknownIntestinal Colonization With Multidrug-resistant BacteriaIsrael, Switzerland, France, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingAcute Myeloid LeukemiaUnited States, Canada, Puerto Rico, Australia